This week brings results from several key positions in my portfolio. Here is an overview with my take on each, supported by a rationale.
$KO : I expect a standard report with minimal surprises; in turbulent times this is a stock that holds its value and serves as a safer haven. Rationale: Consensus estimates Q4 2025 EPS $0.57 (+3.6... Read more
I see that shares of $HIMS have fallen more than 60% from their all-time highs (ATH), which is no small amount. I personally don't follow this company closely right now, but I'd be interested to know the main reasons for this decline.
Does anyone have any idea why $HIMS shares have dropped so significantly? Do you see it more as an opportunity or as a trap?
I own some and I'm considering buying more. They have excellent results, the market is large, and they've even started international expansion in telehealth. The market may be wondering whether that rapid growth is sustainable. And in the US everyone is probably nervous about Trump's interference in this segment. They'll likely be sparring again with the big US market player, company $NVO, over the weight-loss drug they devised themselves, with Wegovy as their benchmark. It probably isn't for someone who doesn't like big swings, but their business model is hard to deny.
Bitcoin is already very volatile, and multiplying that volatility by betting on something that, if it collapses, won’t leave so much as ashes — I can understand that from people who are well off, who can tell themselves in advance that if they lose it, their life won’t change. But for the average investor, at most 5% of the portfolio, and I’d have to look myself in the mirror and admit that I know I’m a gambler 😉.
Based on an analysis of my portfolio and the current market situation, I have three scenarios outlined for the short/medium-term outlook. I note that these scenarios are developed for my portfolio, which does not have a high correlation with the S&P 500.
Optimistic scenario: We can expect another decline of 3–5%, then a short period of... Read more
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
AT&T delivers steady cash flow, but lacks a clear growth catalyst
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Oracle Rallies as AI Cloud Demand and Strategic Growth Catalysts Drive Gains
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
UnitedHealth posts record revenue, but cost pressure clouds the outlook
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
$4 billion in orders and satellites about to go live: execution finally takes center stage
Results from companies in my portfolio this week
This week brings results from several key positions in my portfolio. Here is an overview with my take on each, supported by a rationale.
$KO : I expect a standard report with minimal surprises; in turbulent times this is a stock that holds its value and serves as a safer haven. Rationale: Consensus estimates Q4 2025 EPS $0.57 (+3.6...
Read more
Zobrazit další komentáře
I'll be very interested in inflation, because it can change a lot of things again.
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
The Most Distressed Stocks in the DAX in 2026
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Boeing returns to profit, but the recovery remains fragile
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Fiserv’s Upcoming Earnings Report Is a Litmus Test for Investor Confidence
I see that shares of $HIMS have fallen more than 60% from their all-time highs (ATH), which is no small amount. I personally don't follow this company closely right now, but I'd be interested to know the main reasons for this decline.
Does anyone have any idea why $HIMS shares have dropped so significantly? Do you see it more as an opportunity or as a trap?
Zobrazit další komentáře
I own some and I'm considering buying more. They have excellent results, the market is large, and they've even started international expansion in telehealth. The market may be wondering whether that rapid growth is sustainable. And in the US everyone is probably nervous about Trump's interference in this segment. They'll likely be sparring again with the big US market player, company $NVO, over the weight-loss drug they devised themselves, with Wegovy as their benchmark. It probably isn't for someone who doesn't like big swings, but their business model is hard to deny.
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
PepsiCo Adjusts Pricing Strategy as Snack & Beverage Costs Fall and Future Growth Takes Shape
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
$MSTR vs. $BTCUSD in practice
So many of you wrote under my posts about $MSTR asking why I don’t buy Bitcoin instead.
Let’s look at it in practice, using today as an example.
Bitcoin gained +11% today, which is respectable, while $MSTR managed +26% over the same period. Let’s see why.
Why $MSTR posts larger percentage moves than $BTCUSD:
Financial leverage: The company buys BTC with...
Read more
Zobrazit další komentáře
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Bitcoin is already very volatile, and multiplying that volatility by betting on something that, if it collapses, won’t leave so much as ashes — I can understand that from people who are well off, who can tell themselves in advance that if they lose it, their life won’t change. But for the average investor, at most 5% of the portfolio, and I’d have to look myself in the mirror and admit that I know I’m a gambler 😉.
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Philip Morris delivers through smoke-free growth as dividends remain firmly intact
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Stellantis Faces Historic Sell-Off After Massive Write-Down and Shifting EV Strategy
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
A discounted chemical heavyweight targets $1.5bn in recurring EBITDA by 2028
My scenarios for the coming days and weeks
Based on an analysis of my portfolio and the current market situation, I have three scenarios outlined for the short/medium-term outlook. I note that these scenarios are developed for my portfolio, which does not have a high correlation with the S&P 500.
Optimistic scenario: We can expect another decline of 3–5%, then a short period of...
Read more
Zobrazit další komentáře
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
I don't have scenarios, I'm a long-term investor.